Tianda Pharmaceuticals Limited (HKG:0455)
0.1410
0.00 (0.00%)
May 30, 2025, 10:35 AM HKT
Tianda Pharmaceuticals Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | -61.37 | -24.16 | -54.64 | -19.77 | -27.14 | Upgrade
|
Depreciation & Amortization | 36.28 | 34.47 | 48.25 | 20.03 | 19.28 | Upgrade
|
Other Amortization | 1.95 | 1.94 | 2 | 2.12 | 1.33 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.1 | -0.14 | -1.25 | -12.03 | 0.07 | Upgrade
|
Asset Writedown & Restructuring Costs | 1.34 | - | - | 1.58 | - | Upgrade
|
Loss (Gain) From Sale of Investments | - | - | 0.12 | 0.02 | 0.02 | Upgrade
|
Provision & Write-off of Bad Debts | -0.6 | 0.79 | 0.62 | 0.44 | -0.05 | Upgrade
|
Other Operating Activities | -2.16 | -4.68 | -7.07 | -20.04 | -8.44 | Upgrade
|
Change in Accounts Receivable | 26 | 33.31 | -14.63 | 9.08 | -45.1 | Upgrade
|
Change in Inventory | 23.5 | -18.9 | 19.23 | -8.68 | -11.39 | Upgrade
|
Change in Accounts Payable | 4.85 | 35.48 | -32.97 | 13.41 | 55.16 | Upgrade
|
Change in Other Net Operating Assets | -39.6 | -107.86 | 142.23 | 5.62 | -21.39 | Upgrade
|
Operating Cash Flow | -9.7 | -49.76 | 101.9 | -8.23 | -37.63 | Upgrade
|
Capital Expenditures | -20.61 | -49.28 | -33.28 | -53.76 | -145.68 | Upgrade
|
Sale of Property, Plant & Equipment | 0.09 | 0.28 | 1.63 | 0.03 | 0 | Upgrade
|
Divestitures | - | - | - | 151.9 | - | Upgrade
|
Sale (Purchase) of Intangibles | -16.88 | -17 | - | - | -0.77 | Upgrade
|
Investment in Securities | -10.86 | -6.14 | 14.49 | -13.77 | 5.27 | Upgrade
|
Other Investing Activities | 16.48 | 3.03 | 4.34 | 1.95 | 3.44 | Upgrade
|
Investing Cash Flow | -31.78 | -69.1 | -12.81 | 86.35 | -137.73 | Upgrade
|
Long-Term Debt Issued | 75.92 | 43.46 | - | 33.46 | 110.61 | Upgrade
|
Total Debt Issued | 75.92 | 43.46 | 21.54 | 33.46 | 110.61 | Upgrade
|
Long-Term Debt Repaid | -100.98 | -70.03 | - | -25.31 | -10.38 | Upgrade
|
Total Debt Repaid | -100.98 | -70.03 | -36.68 | -25.31 | -10.38 | Upgrade
|
Net Debt Issued (Repaid) | -25.06 | -26.58 | -15.14 | 8.15 | 100.22 | Upgrade
|
Common Dividends Paid | -5.59 | -5.59 | -23.5 | -8.56 | -2.53 | Upgrade
|
Other Financing Activities | - | -25.23 | 0.12 | -0.89 | -6.94 | Upgrade
|
Financing Cash Flow | -30.65 | -57.39 | -38.52 | -1.3 | 90.75 | Upgrade
|
Foreign Exchange Rate Adjustments | -4.63 | -1.58 | -42.21 | 8.93 | 20.9 | Upgrade
|
Net Cash Flow | -76.75 | -177.84 | 8.37 | 85.76 | -63.72 | Upgrade
|
Free Cash Flow | -30.3 | -99.04 | 68.63 | -61.98 | -183.32 | Upgrade
|
Free Cash Flow Margin | -9.18% | -18.61% | 12.55% | -12.16% | -38.65% | Upgrade
|
Free Cash Flow Per Share | -0.01 | -0.05 | 0.03 | -0.03 | -0.09 | Upgrade
|
Cash Interest Paid | 4.85 | 4.95 | 6.72 | - | 0.57 | Upgrade
|
Cash Income Tax Paid | 5.96 | -0.37 | 0.41 | - | 3.57 | Upgrade
|
Levered Free Cash Flow | -71.25 | -112.42 | - | 101.92 | -184.5 | Upgrade
|
Unlevered Free Cash Flow | -68.22 | -109.33 | - | 102.37 | -184.14 | Upgrade
|
Change in Net Working Capital | 35.12 | 61.31 | - | -161.54 | 36.83 | Upgrade
|
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.